Official name: | Arab Republic of Egypt |
---|---|
WRLFMD code: | EGY |
FMD first recorded: | |
FMD eradicated: | |
Subsequent outbreaks: | |
Serotypes (last rpt): | |
Current status: | Endemic |
Useful websites: |
FMDV Serotype | Years (not comprehensive) |
---|---|
Untyped | 2008, 2009, 2011-2015, 2017, 2018 |
O | 1951, 1958, 1961-1962, 1964-1977, 1978-1982, 1987, 1989-1994, 1997, 2000, 2006-2009, 2011-2017, 2021, 2022 |
A | 1952 (or 1953?), 1956, 1958, 1972, 2006, 2009-2013, 2015-2018, 2020-2022 |
C | - |
Asia 1 | - |
SAT 1 | - |
SAT 2 | 1950, 2012, 2014-2018 |
SAT 3 | - |
Notes | - |
WRLFMD batch no. | Date Received | Type | Virus samples | Topotype | Lineage | Sublineage | WRLFMD Reports |
---|---|---|---|---|---|---|---|
WRLFMD/2006/00007 | 19/02/2006 | A | EGY/1/2006 | AFRICA | G-VII | KEN-05 | Detection Genotyping(A) Vaccine(A) Vaccine(A,sup1) Vaccine(A,sup2) Vaccine(A,sup3) |
A | EGY/2/2006 | AFRICA | G-VII | KEN-05 | |||
WRLFMD/2006/00008 | 01/03/2006 | A | EGY/3/2006 | AFRICA | G-VII | KEN-05 | Detection |
A | EGY/4/2006 | AFRICA | G-VII | KEN-05 | |||
A | EGY/5/2006 | AFRICA | G-VII | KEN-05 | |||
WRLFMD/2007/00010 | 27/04/2007 | O | EGY/8/2006 | ME-SA | Sharqia-72 | - | Detection Genotyping(O) Genotyping(A) Vaccine(A) |
A | EGY/6/2006 | AFRICA | G-VII | KEN-05 | |||
A | EGY/7/2006 | AFRICA | G-VII | KEN-05 | |||
A | EGY/9/2006 | AFRICA | G-VII | KEN-05 | |||
WRLFMD/2007/00144 | 12/10/2007 | O (GD) | EGY/25/2007 | ME-SA | PanAsia-2 | - | Detection Genotyping(O) |
O (GD) | EGY/26/2007 | ME-SA | PanAsia-2 | - | |||
O (GD) | EGY/27/2007 | ME-SA | PanAsia-2 | - | |||
O (GD) | EGY/28/2007 | ME-SA | PanAsia-2 | - | |||
O (GD) | EGY/29/2007 | ME-SA | PanAsia-2 | - | |||
O (GD) | EGY/30/2007 | ME-SA | PanAsia-2 | - | |||
O (GD) | EGY/31/2007 | ME-SA | PanAsia-2 | - | |||
NVD | EGY/1/2007 | ||||||
NVD | EGY/2/2007 | ||||||
NVD | EGY/3/2007 | ||||||
NVD | EGY/4/2007 | ||||||
NVD | EGY/5/2007 | ||||||
NVD | EGY/6/2007 | ||||||
NVD | EGY/7/2007 | ||||||
NVD | EGY/8/2007 | ||||||
NVD | EGY/9/2007 | ||||||
NVD | EGY/10/2007 | ||||||
NVD | EGY/11/2007 | ||||||
NVD | EGY/12/2007 | ||||||
NVD | EGY/13/2007 | ||||||
NVD | EGY/14/2007 | ||||||
NVD | EGY/15/2007 | ||||||
NVD | EGY/16/2007 | ||||||
NVD | EGY/17/2007 | ||||||
NVD | EGY/18/2007 | ||||||
NVD | EGY/19/2007 | ||||||
NVD | EGY/20/2007 | ||||||
NVD | EGY/21/2007 | ||||||
NVD | EGY/22/2007 | ||||||
NVD | EGY/23/2007 | ||||||
NVD | EGY/24/2007 | ||||||
NVD | EGY/32/2007 | ||||||
NVD | EGY/33/2007 | ||||||
NVD | EGY/34/2007 | ||||||
NVD | EGY/35/2007 | ||||||
NVD | EGY/36/2007 | ||||||
NVD | EGY/37/2007 | | |||||
WRLFMD/2009/00012 | 19/03/2009 | O | EGY/10/2006 | ME-SA | Sharqia-72 | - | Detection Genotyping(O) Genotyping(A) Vaccine(O) Vaccine(A) |
O | EGY/11/2006 | ME-SA | Sharqia-72 | - | |||
O | EGY/1/2008 | ME-SA | Sharqia-72 | - | |||
O | EGY/3/2008 | ME-SA | Sharqia-72 | - | |||
O | EGY/4/2008 | ME-SA | Sharqia-72 | - | |||
O | EGY/5/2008 | ME-SA | Sharqia-72 | - | |||
O | EGY/7/2008 | ME-SA | Sharqia-72 | - | |||
O | EGY/1/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/6/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/8/2009 | ME-SA | Sharqia-72 | - | |||
A | EGY/3/2009 | AFRICA | G-VII | KEN-05 | |||
A | EGY/4/2009 | AFRICA | G-VII | KEN-05 | |||
A | EGY/7/2009 | AFRICA | G-VII | KEN-05 | |||
A | EGY/9/2009 | AFRICA | G-VII | KEN-05 | |||
A | EGY/12/2009 | AFRICA | G-VII | KEN-05 | |||
A | EGY/13/2009 | AFRICA | G-VII | KEN-05 | |||
A | EGY/14/2009 | AFRICA | G-VII | KEN-05 | |||
A | EGY/15/2009 | AFRICA | G-VII | KEN-05 | |||
A | EGY/16/2009 | AFRICA | G-VII | KEN-05 | |||
A+O | EGY/8/2009 | nd | - | - | |||
A+O | EGY/10/2009 | nd | - | - | |||
FMDV‑GD | EGY/2/2008 | nd | - | - | |||
FMDV‑GD | EGY/6/2008 | nd | - | - | |||
FMDV‑GD | EGY/5/2009 | nd | - | - | |||
NVD | EGY/2/2009 | ||||||
NVD | EGY/11/2009 | ||||||
WRLFMD/2009/00028 | 28/05/2009 | O | EGY/17/2009 | ME-SA | Sharqia-72 | - | Detection Genotyping(O) Vaccine(O) |
O | EGY/18/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/19/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/20/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/21/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/22/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/23/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/24/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/25/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/26/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/27/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/28/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/29/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/30/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/31/2009 | ME-SA | Sharqia-72 | - | |||
O | EGY/32/2009 | ME-SA | Sharqia-72 | - | |||
WRLFMD/2012/00011 | 12/03/2012 | O | EGY/6/2011 | ME-SA | PanAsia-2 | - | Detection Genotyping(A) Genotyping(SAT2) Vaccine(O) Vaccine(A) Vaccine(SAT2) Vaccine(SAT2, sup) |
O | EGY/7/2011 | ME-SA | PanAsia-2 | - | |||
O | EGY/10/2011 | ME-SA | PanAsia-2 | - | |||
A | EGY/1/2010 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/2/2010 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/3/2010 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/2/2011 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/5/2011 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/8/2011 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/9/2011 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/1/2012 | AFRICA | G-IV | ISM-12 | |||
SAT 2 | EGY/2/2012 | VII | Alx-12 | - | |||
SAT 2 | EGY/3/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/4/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/5/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/6/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/9/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/10/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/11/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/13/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/14/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/15/2012 | VII | Ghb-12 | - | |||
FMDV‑GD | EGY/1/2011 | nd | - | - | |||
FMDV‑GD | EGY/3/2011 | nd | - | - | |||
FMDV‑GD | EGY/4/2011 | nd | - | - | |||
FMDV‑GD | EGY/7/2012 | nd | - | - | |||
FMDV‑GD | EGY/8/2012 | nd | - | - | |||
NVD | EGY/12/2012 | ||||||
WRLFMD/2012/00032 | 02/10/2012 | O | EGY/19/2012 | EA-3 | unnamed | - | Detection Genotyping(O) Genotyping(O,sup) Genotyping(A) Genotyping (SAT2) Vaccine(O) Vaccine(O,sup) Vaccine(A) Vaccine(SAT2) |
O | EGY/25/2012 | EA-3 | unnamed | - | |||
O | EGY/26/2012 | EA-3 | unnamed | - | |||
O | EGY/27/2012 | EA-3 | unnamed | - | |||
A | EGY/18/2012 | AFRICA | G-IV | - | |||
A | EGY/20/2012 | AFRICA | G-IV | - | |||
A | EGY/30/2012 | AFRICA | G-IV | - | |||
SAT 2 | EGY/16/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/17/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/21/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/22/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/28/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/29/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/31/2012 | VII | Ghb-12 | - | |||
FMDV‑GD | EGY/23/2012 | nd | - | - | |||
FMDV‑GD | EGY/24/2012 | nd | - | - | |||
FMDV‑GD | EGY/35/2012 | nd | - | - | |||
FMDV‑GD | EGY/36/2012 | nd | - | - | |||
NVD | EGY/32/2012 | ||||||
NVD | EGY/33/2012 | ||||||
NVD | EGY/34/2012 | ||||||
WRLFMD/2013/00012 | 29/05/2013 | A | EGY/3/2013 | ASIA | Iran-05 | BAR-08 | Detection Genotyping(A) Vaccine(A) Vaccine(A,sup) |
A | EGY/5/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/6/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/11/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/12/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/13/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/14/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/15/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/17/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/19/2013 | ASIA | Iran-05 | BAR-08 | |||
FMDV‑GD | EGY/37/2012 | nd | - | - | |||
FMDV‑GD | EGY/38/2012 | nd | - | - | |||
FMDV‑GD | EGY/40/2012 | nd | - | - | |||
FMDV‑GD | EGY/1/2013 | nd | - | - | |||
FMDV‑GD | EGY/2/2013 | nd | - | - | |||
FMDV‑GD | EGY/4/2013 | nd | - | - | |||
FMDV‑GD | EGY/7/2013 | nd | - | - | |||
FMDV‑GD | EGY/8/2013 | nd | - | - | |||
FMDV‑GD | EGY/9/2013 | nd | - | - | |||
NVD | EGY/39/2012 | ||||||
NVD | EGY/41/2012 | ||||||
NVD | EGY/10/2013 | ||||||
NVD | EGY/16/2013 | ||||||
NVD | EGY/18/2013 | ||||||
NVD | EGY/20/2013 | ||||||
WRLFMD/2014/00017 | 23/04/2014 | O | EGY/24/2013 | EA-3 | unnamed | - | Detection Genotyping(O) Genotyping(A) Genotyping(SAT 2) Vaccine(O) Vaccine(A) Vaccine(SAT 2) |
O | EGY/25/2013 | EA-3 | unnamed | - | |||
O | EGY/28/2013 | EA-3 | unnamed | - | |||
O | EGY/29/2013 | EA-3 | unnamed | - | |||
O | EGY/1/2014 | EA-3 | unnamed | - | |||
O | EGY/3/2014 | EA-3 | unnamed | - | |||
O | EGY/4/2014 | EA-3 | unnamed | - | |||
O | EGY/5/2014 | EA-3 | unnamed | - | |||
O | EGY/6/2014 | EA-3 | unnamed | - | |||
O | EGY/10/2014 | EA-3 | unnamed | - | |||
O | EGY/18/2014 | EA-3 | unnamed | - | |||
A | EGY/21/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/22/2013 | ASIA | Iran-05 | BAR-08 | |||
SAT 2 | EGY/11/2014 | VII | Alx-12 | - | |||
SAT 2 | EGY/20/2014 | VII | Alx-12 | - | |||
SAT 2 | EGY/22/2014 | VII | Alx-12 | - | |||
FMDV‑GD | EGY/23/2013 | nd | - | - | |||
FMDV‑GD | EGY/27/2013 | nd | - | - | |||
FMDV‑GD | EGY/7/2014 | nd | - | - | |||
FMDV‑GD | EGY/8/2014 | nd | - | - | |||
FMDV‑GD | EGY/9/2014 | nd | - | - | |||
FMDV‑GD | EGY/12/2014 | nd | - | - | |||
FMDV‑GD | EGY/13/2014 | nd | - | - | |||
FMDV‑GD | EGY/14/2014 | nd | - | - | |||
FMDV‑GD | EGY/15/2014 | nd | - | - | |||
FMDV‑GD | EGY/16/2014 | nd | - | - | |||
FMDV‑GD | EGY/19/2014 | nd | - | - | |||
FMDV‑GD | EGY/21/2014 | nd | - | - | |||
NVD | EGY/26/2013 | ||||||
NVD | EGY/2/2014 | ||||||
NVD | EGY/17/2014 | ||||||
WRLFMD/2014/00037 | 04/11/2014 | O | EGY/23/2014 | EA-3 | unnamed | - | Detection Genotyping(A) Genotyping(SAT 2) Vaccine(O) Vaccine(SAT 2) |
O | EGY/25/2014 | EA-3 | unnamed | - | |||
O | EGY/26/2014 | EA-3 | unnamed | - | |||
O | EGY/27/2014 | EA-3 | unnamed | - | |||
O | EGY/28/2014 | EA-3 | unnamed | - | |||
O | EGY/29/2014 | EA-3 | unnamed | - | |||
O | EGY/32/2014 | EA-3 | unnamed | - | |||
O | EGY/34/2014 | EA-3 | unnamed | - | |||
O | EGY/36/2014 | EA-3 | unnamed | - | |||
A | EGY/42/2012 | AFRICA | G-IV | - | |||
A | EGY/30/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/31/2013 | ASIA | Iran-05 | BAR-08 | |||
A | EGY/31/2014 | ASIA | Iran-05 | BAR-08 | |||
SAT 2 | EGY/43/2012 | VII | Ghb-12 | - | |||
SAT 2 | EGY/24/2014 | VII | Alx-12 | - | |||
FMDV‑GD | EGY/30/2014 | nd | - | - | |||
FMDV‑GD | EGY/33/2014 | nd | - | - | |||
FMDV‑GD | EGY/35/2014 | nd | - | - | |||
NVD | EGY/37/2014 | ||||||
NVD | EGY/38/2014 | ||||||
NVD | EGY/39/2014 | ||||||
NVD | EGY/40/2014 | ||||||
NVD | EGY/41/2014 | ||||||
NVD | EGY/42/2014 | ||||||
NVD | EGY/43/2014 | ||||||
NVD | EGY/44/2014 | ||||||
NVD | EGY/45/2014 | ||||||
NVD | EGY/46/2014 | ||||||
WRLMEG/2015/00010 | 15/07/2015 | O | RL-440/EGY/2014* | EA-3 | unnamed | - | Genotyping(O) Genotyping(A) |
O | RL-453/EGY/2014* | EA-3 | unnamed | - | |||
O | RL-455/EGY/2014* | EA-3 | unnamed | - | |||
O | RL-902/EGY/2015* | EA-3 | unnamed | - | |||
O | RL-936/EGY/2015* | EA-3 | unnamed | - | |||
O | RL-937/EGY/2015* | EA-3 | unnamed | - | |||
O | RL-939/EGY/2015* | EA-3 | unnamed | - | |||
O | RL-940/EGY/2015* | EA-3 | unnamed | - | |||
A | RL-464/EGY/2014* | ASIA | Iran-05 | BAR-08 | |||
A | RL-932/EGY/2015* | ASIA | Iran-05 | BAR-08 | |||
WRLFMD/2016/00017 | 14/06/2016 | O | EGY/11/2011 | ME-SA | Sharqia‑72 | - | Detection Genotyping(O) Vaccine |
SAT2 | EGY/44/2012 | VII | Ghb‑12 | - | |||
NVD | EGY/1/2015 | ||||||
WRLFMD/2016/00024 | 14/06/2016 | O | EGY/3/2015 | EA-3 | unnamed | - | Detection Genotyping(O) Genotyping(A) Genotyping(SAT 2) Vaccine |
O | EGY/9/2015 | EA-3 | unnamed | - | |||
O | EGY/10/2015 | EA-3 | unnamed | - | |||
O | EGY/11/2015 | EA-3 | unnamed | - | |||
O | EGY/13/2015 | EA-3 | unnamed | - | |||
O | EGY/14/2015 | EA-3 | unnamed | - | |||
O | EGY/4/2016 | EA-3 | unnamed | - | |||
O | EGY/5/2016 | EA-3 | unnamed | - | |||
O | EGY/7/2016 | EA-3 | unnamed | - | |||
O | EGY/8/2016 | EA-3 | unnamed | - | |||
O | EGY/9/2016 | EA-3 | unnamed | - | |||
O | EGY/10/2016 | EA-3 | unnamed | - | |||
O | EGY/11/2016 | EA-3 | unnamed | - | |||
O | EGY/12/2016 | EA-3 | unnamed | - | |||
O | EGY/14/2016 | EA-3 | unnamed | - | |||
O | EGY/16/2016 | EA-3 | unnamed | - | |||
O | EGY/17/2016 | EA-3 | unnamed | - | |||
O | EGY/18/2016 | EA-3 | unnamed | - | |||
A | EGY/8/2015 | AFRICA | G-IV | - | |||
A | EGY/3/2016 | AFRICA | G-IV | - | |||
SAT 2 | EGY/5/2015 | VII | Alx-12 | - | |||
FMDV‑GD | EGY/2/2015 | nd | - | - | |||
NVD | EGY/4/2015 | ||||||
NVD | EGY/6/2015 | ||||||
NVD | EGY/7/2015 | ||||||
NVD | EGY/12/2015 | ||||||
NVD | EGY/15/2015 | ||||||
NVD | EGY/1/2016 | ||||||
NVD | EGY/2/2016 | ||||||
NVD | EGY/6/2016 | ||||||
NVD | EGY/13/2016 | ||||||
NVD | EGY/15/2016 | ||||||
WRLFMD/2017/00014 | 05/07/2017 | O | EGY/4/2017 | EA-3 | unnamed | - | Detection Genotyping(O) Genotyping(A) Vaccine |
O | EGY/6/2017 | EA-3 | unnamed | - | |||
O | EGY/7/2017 | EA-3 | unnamed | - | |||
O | EGY/8/2017 | EA-3 | unnamed | - | |||
O | EGY/9/2017 | EA-3 | unnamed | - | |||
O | EGY/10/2017 | EA-3 | unnamed | - | |||
O | EGY/11/2017 | EA-3 | unnamed | - | |||
O | EGY/13/2017 | EA-3 | unnamed | - | |||
O | EGY/16/2017 | EA-3 | unnamed | - | |||
O | EGY/17/2017 | EA-3 | unnamed | - | |||
O | EGY/19/2017 | EA-3 | unnamed | - | |||
O | EGY/21/2017 | EA-3 | unnamed | - | |||
O | EGY/22/2017 | EA-3 | unnamed | - | |||
O | EGY/25/2017 | EA-3 | unnamed | - | |||
O | EGY/26/2017 | EA-3 | unnamed | - | |||
O | EGY/27/2017 | EA-3 | unnamed | - | |||
O | EGY/28/2017 | EA-3 | unnamed | - | |||
O | EGY/30/2017 | EA-3 | unnamed | - | |||
O | EGY/31/2017 | EA-3 | unnamed | - | |||
O | EGY/32/2017 | EA-3 | unnamed | - | |||
O | EGY/33/2017 | EA-3 | unnamed | - | |||
A | EGY/19/2016 | AFRICA | G-IV | - | |||
FMDV‑GD | EGY/1/2017 | nd | - | - | |||
FMDV‑GD | EGY/2/2017 | nd | - | - | |||
FMDV‑GD | EGY/5/2017 | nd | - | - | |||
FMDV‑GD | EGY/12/2017 | nd | - | - | |||
FMDV‑GD | EGY/14/2017 | nd | - | - | |||
FMDV‑GD | EGY/15/2017 | nd | - | - | |||
FMDV‑GD | EGY/20/2017 | nd | - | - | |||
FMDV‑GD | EGY/23/2017 | nd | - | - | |||
FMDV‑GD | EGY/24/2017 | nd | - | - | |||
FMDV‑GD | EGY/29/2017 | nd | - | - | |||
NVD | EGY/20/2016 | ||||||
NVD | EGY/3/2017 | ||||||
NVD | EGY/18/2017 | ||||||
WRLMEG/2018/00004 | 16/01/2018 | O | Ismailia 12/Egy/2016* | EA-3 | - | - | Genotyping(O) Genotyping(A) Genotyping(SAT 2) |
O | Ismailia 13/Egy/2016* | EA-3 | - | - | |||
O | Alexandria 1/Egy/2016* | EA-3 | - | - | |||
O | Alexandria 1/Egy/2017* | EA-3 | - | - | |||
O | Giza 1/Egy/2017* | EA-3 | - | - | |||
O | Cairo 1/Egy/2017* | EA-3 | - | - | |||
O | Sharkia 1/Egy/2017* | EA-3 | - | - | |||
O | Gharbia 1/Egy/2017* | EA-3 | - | - | |||
O | Behira 1/Egy/2017* | EA-3 | - | - | |||
O | Behira 2/Egy/2017* | EA-3 | - | - | |||
O | Fayoum 1/Egy/2017* | EA-3 | - | - | |||
O | Fayoum 2/Egy/2017* | EA-3 | - | - | |||
O | Fayoum 3/Egy/2017* | EA-3 | - | - | |||
O | Fayoum 4/Egy/2017* | EA-3 | - | - | |||
O | Fayoum 5/Egy/2017* | EA-3 | - | - | |||
A | Beni-suef 1/Egy/2017* | AFRICA | G-IV | - | |||
SAT 2 | Daqahlia 1/Egy/2017* | VII | Alx-12 | - | |||
SAT 2 | Daqahlia 2/Egy/2017* | VII | Alx-12 | - | |||
SAT 2 | Fayoum 1/Egy/2017* | VII | Alx-12 | - | |||
WRLFMD/2019/00005 | 16/01/2019 | O | EGY/34/2017 | EA‑3 | - | - | Detection Genotyping(O) Genotyping(A) Genotyping(SAT2) Vaccine Vaccine(sup) |
A | EGY/2/2018 | AFRICA | G‑IV | - | |||
SAT 2 | EGY/1/2018 | VII | Ghb‑12 | - | |||
SAT 2 | EGY/7/2018 | VII | Lib‑12 | - | |||
SAT 2 | EGY/19/2018 | VII | Lib‑12 | - | |||
SAT 2 | EGY/21/2018 | VII | Lib‑12 | - | |||
SAT 2 | EGY/31/2018 | VII | Lib‑12 | - | |||
SAT 2 | EGY/34/2018 | VII | Lib‑12 | - | |||
FMDV‑GD | EGY/3/2018 | nd | - | - | |||
FMDV‑GD | EGY/5/2018 | nd | - | - | |||
FMDV‑GD | EGY/9/2018 | nd | - | - | |||
FMDV‑GD | EGY/10/2018 | nd | - | - | |||
FMDV‑GD | EGY/11/2018 | nd | - | - | |||
FMDV‑GD | EGY/12/2018 | nd | - | - | |||
FMDV‑GD | EGY/16/2018 | nd | - | - | |||
FMDV‑GD | EGY/17/2018 | nd | - | - | |||
FMDV‑GD | EGY/18/2018 | nd | - | - | |||
FMDV‑GD | EGY/20/2018 | nd | - | - | |||
FMDV‑GD | EGY/25/2018 | nd | - | - | |||
FMDV‑GD | EGY/26/2018 | nd | - | - | |||
FMDV‑GD | EGY/27/2018 | nd | - | - | |||
FMDV‑GD | EGY/28/2018 | nd | - | - | |||
FMDV‑GD | EGY/29/2018 | nd | - | - | |||
FMDV‑GD | EGY/30/2018 | nd | - | - | |||
FMDV‑GD | EGY/32/2018 | nd | - | - | |||
FMDV‑GD | EGY/33/2018 | nd | - | - | |||
FMDV‑GD | EGY/35/2018 | nd | - | - | |||
NVD | EGY/4/2018 | ||||||
NVD | EGY/6/2018 | ||||||
NVD | EGY/8/2018 | ||||||
NVD | EGY/13/2018 | ||||||
NVD | EGY/14/2018 | ||||||
NVD | EGY/15/2018 | ||||||
NVD | EGY/22/2018 | ||||||
NVD | EGY/23/2018 | ||||||
NVD | EGY/24/2018 | | | ||||
WRLMEG/2020/00004 | 28/01/2020 | SAT 2 | EGY/Sharqia1/2018* | VII | Lib-12 | - | Genotyping(SAT2) |
SAT 2 | EGY/Sharqia2/2018* | VII | Lib-12 | - | |||
SAT 2 | EGY/Sharqia3/2018* | VII | Lib-12 | - | |||
SAT 2 | EGY/Sharqia4/2018* | VII | Lib-12 | - | |||
SAT 2 | EGY/Ismailia1/2018* | VII | Lib-12 | - | |||
SAT 2 | EGY/Ismailia2/2018* | VII | Lib-12 | - | |||
SAT 2 | EGY/Ismailia3/2018* | VII | Lib-12 | - | |||
SAT 2 | EGY/Ismailia4/2018* | VII | Lib-12 | - | |||
SAT 2 | EGY/Alexandria1/2018* | VII | Lib-12 | - | |||
SAT 2 | EGY/Alexandria2/2018* | VII | Lib-12 | - | |||
SAT 2 | EGY/Alexandria3/2018* | VII | Lib-12 | - | |||
WRLMEG/2022/00019 | 25/06/2022 | O | Egy/Sharquia1/22 * | EURO-SA | - | - | Genotyping(O) |
WRLFMD/2022/000090 | 08/12/2022 | O | EGY 8/2021 | EA-3 | - | - | Detection Genotyping(O) Genotyping(A) Vaccine |
O | EGY 9/2021 | EA-3 | - | - | |||
O | EGY 10/2021 | EA-3 | - | - | |||
A | EGY 2/2020 | Africa | G-IV | - | |||
A | EGY 9/2020 | Africa | G-IV | - | |||
A | EGY 13/2020 | Africa | G-IV | - | |||
A | EGY 14/2020 | Africa | G-IV | - | |||
A | EGY 17/2020 | Africa | G-IV | - | |||
A | EGY 18/2020 | Africa | G-IV | - | |||
A | EGY 19/2020 | Africa | G-IV | - | |||
A | EGY 20/2020 | Africa | G-IV | - | |||
A | EGY 21/2020 | Africa | G-IV | - | |||
A | EGY 1/2021 | Africa | G-IV | - | |||
A | EGY 5/2021 | Africa | G-IV | - | |||
A | EGY 7/2021 | Africa | G-IV | - | |||
A | EGY 1/2022 | Africa | G-IV | - | |||
A† | EGY 7/2020 | Africa | G-IV | - | |||
A† | EGY 2/2022 | EURO-SA | - | - | |||
NVD | EGY 1/2020 | ||||||
NVD | EGY 3/2020 | ||||||
NVD | EGY 4/2020 | ||||||
NVD | EGY 5/2020 | ||||||
NVD | EGY 6/2020 | ||||||
NVD | EGY 8/2020 | ||||||
NVD | EGY 10/2020 | ||||||
NVD | EGY 11/2020 | ||||||
NVD | EGY 12/2020 | ||||||
NVD | EGY 15/2020 | ||||||
NVD | EGY 16/2020 | ||||||
NVD | EGY 2/2021 | ||||||
NVD | EGY 3/2021 | ||||||
NVD | EGY 4/2021 | ||||||
NVD | EGY 6/2021 | ||||||
NVD | EGY 3/2022 |
Notes:
nd, not done
*, Not a WRLFMD reference number (only VP1 sequence received)
†, originally reported as FMDV‑GD.